August 26, 2025 — Leads & Copy — Vera Therapeutics, Inc. (Nasdaq: VERA) will present and participate in one-on-one meetings at upcoming investor conferences.
The Cantor Global Healthcare Conference will feature a fireside chat and 1x1s on Thursday, September 4, 2025, at 9:10am ET in New York, NY. A webcast is available.
The Morgan Stanley 23rd Annual Global Healthcare Conference will also feature a fireside chat and 1x1s on Monday, September 8, 2025, at 5:35pm ET in New York, NY.
A replay of the webcast will be available for 90 days on the Vera Therapeutics website.
Vera Therapeutics is focused on developing treatments for immunological diseases. Its lead product candidate is atacicept, and it is also developing MAU868.
Investor Contact: Joyce Allaire, LifeSci Advisors, 212-915-2569, jallaire@lifesciadvisors.com; Media Contact: Debra Charlesworth, Vera Therapeutics, 415-854-8051, corporatecommunications@veratx.com
Source: Vera Therapeutics
